Abstract

VELASQUEZ-JONES, Luis  and  MEDEIROS-DOMINGO, Mara. Nephrogenic diabetes insipidus. Bol. Med. Hosp. Infant. Mex. [online]. 2014, vol.71, n.6, pp.332-338. ISSN 1665-1146.  https://doi.org/10.1016/j.bmhimx.2015.01.004.

The anti-diuretic hormone arginine-vasopressin (AVP) is released from the pituitary and regulates water reabsorption in the principal cells of the kidney collecting duct. Binding of AVP to the arginine-vasopressin receptor type-2 in the basolateral membrane leads to translocation of aquaporin-2 water channels to the apical membrane of the principal cells of the collecting duct, inducing water permeability of the membrane. This results in water reabsorption in the collecting duct of the nephron following an osmotic gradient. Nephrogenic diabetes insipidus is caused by partial or complete renal resistance to the effects of AVP. Congenital nephrogenic diabetes insipidus is a disorder associated with mutations in either the AVPR2 or AQP2 gene, causing the inability of patients to concentrate their urine. Acquired nephrogenic diabetes insipidus can be caused by electrolyte imbalances (e.g., hypercalcemia, hypokalemia), renal/extra-renal diseases and drugs (e.g., lithium toxicity). This article reviews the causes, clinical manifestations, diagnosis and treatment of patients with nephrogenic diabetes insipidus. Based on more in-depth mechanistic understanding, new therapeutic strategies are current being explored.

Keywords : Nephrogenic diabetes insipidus; Arginine-vasopressin type-2 receptor; Aquaporin-2 water channel; Polyuria.